Does magnesium help prevent migraines?
Moderate EvidenceIT DEPENDS
Moderate evidence supports magnesium supplementation (400-600mg/day) for migraine prevention, with frequency reductions of approximately 40% observed primarily in individuals with documented magnesium deficiency.
The Verdict
Moderate evidence supports magnesium supplementation (400-600mg/day) for migraine prevention, with frequency reductions of approximately 40% observed primarily in individuals with documented magnesium deficiency.
What the Evidence Shows
Magnesium is involved in neurotransmitter release, vasoconstriction, and cortical spreading depression—all implicated in migraine pathophysiology. Multiple studies show migraine sufferers have lower serum and intracellular magnesium levels than controls. Clinical trials demonstrate that oral magnesium supplementation (typically magnesium citrate or oxide at 400-600mg/day) reduces migraine frequency by 20-40% compared to placebo, with the greatest benefit in those with documented low magnesium. The American Academy of Neurology and American Headache Society list magnesium as 'probably effective' (Level B evidence) for migraine prevention. IV magnesium sulfate also shows benefits for acute migraine with aura. However, response rates vary considerably and GI side effects limit tolerability of higher doses.
Evidence Quality
2
Meta-Analyses
9
RCTs
7
Observational
Important Caveats
- ⚠️ Benefits most pronounced in those with documented magnesium deficiency
- ⚠️ Optimal form debated (citrate better absorbed than oxide, but oxide used in key trials)
- ⚠️ GI side effects (diarrhea) common at therapeutic doses (>400mg)
- ⚠️ Takes 3-4 months of daily use to assess efficacy for prevention
- ⚠️ Not all migraine subtypes respond equally
- ⚠️ Serum magnesium is a poor marker—intracellular levels matter more
Population Studied
Adults with episodic migraine (with and without aura); some studies specifically in menstrual migraine
Dosage
400-600mg elemental magnesium daily; most trials used magnesium citrate or magnesium oxide
Duration
Prevention trials typically lasted 12-16 weeks; at least 8 weeks needed to assess response
Supporting Studies (3)
Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study
RCTPeikert A, Wilimzig C, Köhne-Volland R. · Cephalalgia (1996)
Magnesium citrate 600mg/day for 12 weeks reduced migraine attack frequency by 41.6% compared to 15.8% with placebo. Migraine days and severity also significantly decreased.
View paper (DOI) →Why all migraine patients should be treated with magnesium
Systematic ReviewMauskop A, Varughese J. · Journal of Neural Transmission (2012)
Comprehensive review confirmed that up to 50% of migraine patients have magnesium deficiency and that supplementation is effective for prevention with minimal side effects compared to prescription preventives.
View paper (DOI) →Oral magnesium oxide prophylaxis of frequent migrainous headache in children
RCTWang F, Van Den Eeden SK, Ackerson LM, et al. · Headache (2003)
Magnesium oxide (9mg/kg/day) significantly reduced headache frequency and severity in children with frequent migraines compared to placebo over 16 weeks.
View paper (DOI) →Contradicting Studies (1)
A randomized, double-blind, placebo-controlled trial of oral magnesium oxide for migraine prophylaxis
RCTPfaffenrath V, Wessely P, Meyer C, et al. · Cephalalgia (1996)
Magnesium oxide 486mg/day for 12 weeks did not significantly reduce migraine frequency compared to placebo. High dropout rate (45%) due to GI side effects limited statistical power.
Why this disagrees:
The high dropout rate from diarrhea substantially reduced the study's power to detect an effect. Additionally, magnesium oxide has lower bioavailability than citrate, and this trial did not select for magnesium-deficient patients who are most likely to respond.
Related Claims
Does magnesium supplementation improve sleep quality?
Moderate EvidenceModerate evidence suggests magnesium supplementation may improve sleep quality, particularly in older adults and those with low magnesium intake. Effects include reduced time to fall asleep and improved subjective sleep quality.
Does omega-3 supplementation reduce inflammation?
Strong EvidenceStrong evidence shows omega-3 fatty acids (EPA and DHA) reduce inflammatory markers, particularly C-reactive protein and IL-6. Effects are most pronounced in people with elevated baseline inflammation.
Does vitamin D supplementation prevent or treat depression?
Weak EvidenceWeak evidence suggests vitamin D supplementation may modestly reduce depressive symptoms in people who are deficient, but it does not appear effective as a standalone treatment for clinical depression.